Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel®

Biomaterials

Volumn 26, Issue 31, 2005, Pages 6233-6241

  Buchta, Christoph ^a   Hedrich, Hans Christian ^b   Macher, Maria ^a   Höcker, Paul ^a   Redl, Heinz ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b FEDERAL RESEARCH AND TRAINING CENTRE FOR FORESTS   (Austria)

Author keywords

Fibrin cross linking; Fibrin sealant; Fibrinogen; Wound closure

Indexed keywords

BIOCHEMISTRY; DIFFUSION; ENZYME INHIBITION; ORGANIC ACIDS; PLASMAS; PROTEINS; SEALANTS; TISSUE;

AUTOLOGOUS FIBRIN SEALANTS; CLOTTING; PROTEOLYTIC DIGESTION; TRANEXAMIC ACID;

BIOMATERIALS;

APROTININ; BLOOD CLOTTING FACTOR 13A; FIBRIN; FIBRIN GLUE; FIBRINOGEN; PLASMA PROTEIN; PLASMINOGEN; PROTEINASE INHIBITOR; THROMBIN; TRANEXAMIC ACID;

ARTICLE; BIOCOMPATIBILITY; CROSS LINKING; FIBRIN CLOT; LIQUEFACTION; MOLECULAR STABILITY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PROTEINS; FIBRIN TISSUE ADHESIVE; HUMANS; TISSUE ADHESIVES;

EID: 20444439267     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2005.04.014     Document Type: Article

References (23)

1. M.R. Jackson Fibrin sealants in surgical practice: an overview Am J Surg 182S 2001 1 7
2. M. Kawamura, M. Sawafuji, M. Watanabe, H. Horinouchi, and K. Kobayashi Frequency of transmission of Human Parvovirus B19 infection by fibrin sealant used during thoracic surgery Ann Thorac Surg 73 2002 1098 1100
3. B. Evatt, H. Austin, G. Leon, A. Ruiz-Saez, and N. de Bosch Hemophilia treatment. Predicting the long-term risk of HIV exposure by cryoprecipitate Haemophilia 6 Suppl. 1 2000 128 132
4. N. Hunter, and F. Houston Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments Dev Biol (Basel) 108 2002 93 98
5. G.J. Wang, C.A. Goldthwaite Jr, S. Burks, R. Crawford, and W.D. Spotnitz Fibrin sealant reduces perioperative blood loss in total hip replacement J Long Term Eff Med Implants 13 2003 399 411
6. H. Vinazzer Fibrin sealing: physiologic and biochemical background Facial Plast Surg 2 1985 291 295
7. J.G. Pool, and A.E. Shannon Production of high potency concentrates of antihemophilic globulin in a closed bag system N Engl J Med 273 1965 1443 1447
8. M.W. Mosesson Fibrinogen and fibrin polymerization and functions Blood Coagul Fibrinolysis 10 Suppl. 1 1999 S45 S48
9. S.A. Corbett, L. Lee, C.L. Wilson, and J.E. Schwarzbauer Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix J Biol Chem 272 40 1997 24999 25005
10. ® FS System: product chemistry, material properties, and possible preparation in the autologous preoperative setting Vox Sang 86 2004 257 262
11. K. Stocker, H. Fischer, and J. Meier Thrombin-like snake venom proteinases Toxicon 20 1982 265 273
12. ® patient-derived sealant Eur Surg Res 33 2001 399 404
13. H.K. Kjaergard, and U.S. Weis-Fogh Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction time - comparison of strength with commercial fibrin glue. Eur Surg Res 26 1994 273 276
14. D.M. Albala Fibrin sealants in clinical practice Cardiovasc Surg 11 Suppl. 1 2003 5 11
15. L. Lorand Factor XIII: structure, activation, and interactions with fibrinogen and fibrin Ann N Y Acad Sci 936 2001 291 311 (Review)
16. L.L. Shen, J. Hermans, J. McDonagh, R.P. McDonagh, and M. Carr Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin cells Thromb Res 6 3 1975 255 265
17. C.W. Francis, and V.J. Marder Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations Blood 71 5 1988 1361 1365
18. Y. Sakata, and N. Aoki Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor J Clin Invest 65 2 1980 290 297
19. F. Grinnell, M. Feld, and D. Minter Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin) Cell 19 2 1980 517 525
20. A. Pellegrini, D. Giaretta, R. Chemello, L. Zanotto, and G. Testa Feline generalized epilepsy induced by tranexamic acid (AMCA) Epilepsia 23 1982 35 45
21. M.G. Schlag, R. Hopf, and H. Redl Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model Neurosurgery 47 2000 1463 1467
22. O. Levy, U. Martinowitz, A. Oran, C. Tauber, and H. Horoszowski The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty J Bone J Surg Am 81 1999 1580 1588
23. C. Longstaff Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents Blood Coagul Fibrinolysis 5 4 1994 537 542